A New Jersey teenager failed his driver's training road test due to his family's Tesla vehicle. A look at what the instructor ...

Dyne updates DYNE-101 trial timeline, reports strong 12-month data, and receives FDA Breakthrough Therapy status for treating ...

U.S. dollar weakens, boosting the appeal of gold stocks and driving up prices of producers like Agnico Eagle, Newmont, and ...

Compared to its top 4 peers, Amazon.com has a stronger financial position indicated by its lower debt-to-equity ratio of 0.44 ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Meme coin heavyweights Dogecoin (CRYPTO: DOGE) and Shiba Inu (CRYPTO: SHIB) saw sharp daily losses as sentiment across the ...

Processa Pharmaceuticals' stock is surging after licensing a gastroparesis drug to Intact Therapeutics. The deal promises ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...

Mineralys reports Phase 2 trial success for lorundrostat, showing BP and kidney improvements in CKD patients with favorable ...

A new pricing study by ride data platform Obi, found 74% of riders cite safety as their top concern around robotaxis — even ...

Oklo Inc (NYSE:OKLO) shares are trading higher Tuesday after the company announced subsidiary Atomic Alchemy commenced site ...